iShares Global Healthcare ETF (NYSEARCA:IXJ) Reaches New 52-Week High – Should You Buy?

iShares Global Healthcare ETF (NYSEARCA:IXJ)’s stock price hit a new 52-week high on Tuesday . The company traded as high as $102.20 and last traded at $102.11, with a volume of 24947 shares. The stock had previously closed at $100.46.

iShares Global Healthcare ETF Stock Performance

The company has a market cap of $4.14 billion, a P/E ratio of 21.58 and a beta of 0.57. The firm has a 50 day moving average price of $94.53 and a 200-day moving average price of $96.31.

Hedge Funds Weigh In On iShares Global Healthcare ETF

A number of institutional investors have recently modified their holdings of the company. Nvest Wealth Strategies Inc. acquired a new stake in shares of iShares Global Healthcare ETF in the fourth quarter worth $30,000. Arax Advisory Partners acquired a new position in iShares Global Healthcare ETF in the 4th quarter valued at $31,000. Franklin Resources Inc. raised its holdings in iShares Global Healthcare ETF by 80.0% in the 2nd quarter. Franklin Resources Inc. now owns 360 shares of the company’s stock worth $31,000 after acquiring an additional 160 shares during the period. LOM Asset Management Ltd raised its holdings in iShares Global Healthcare ETF by 37.0% in the 4th quarter. LOM Asset Management Ltd now owns 407 shares of the company’s stock worth $40,000 after acquiring an additional 110 shares during the period. Finally, Capital Investment Counsel Inc acquired a new position in iShares Global Healthcare ETF during the 4th quarter worth $42,000.

About iShares Global Healthcare ETF

iShares Global Healthcare ETF (the Fund), formerly iShares S&P Global Healthcare Sector Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the S&P Global 1200 Healthcare Sector Index (the Index). The Index measures the performance of companies that Standards & Poor’s Financial Services LLC (S&P) deems to be a part of the consumer staples sector of the economy. It is a subset of the S&P Global 1200 Index. Component companies include healthcare providers, biotechnology companies and manufacturers of medical supplies, advanced medical devices and pharmaceuticals.